Patent details

EP2900061 Title: METHOD FOR ENHANCING SPECIFIC IMMUNOTHERAPIES IN CANCER TREATMENT

Basic Information

Publication number:
EP2900061
PCT Application Number:
US2013060182
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP138374582
PCT Publication Number:
WO2014043708
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
METHOD FOR ENHANCING SPECIFIC IMMUNOTHERAPIES IN CANCER TREATMENT
French Title of Invention:
PROCÉDÉ POUR L'AMÉLIORATION D'IMMUNOTHÉRAPIES SPÉCIFIQUES DANS LE TRAITEMENT DU CANCER
German Title of Invention:
VERFAHREN ZUR OPTIMIERUNG SPEZIFISCHER IMMUNTHERAPIEN IN DER KREBSBEHANDLUNG
SPC Number:

Dates

Filing date:
17/09/2013
Grant date:
22/01/2020
EP Publication Date:
05/08/2015
PCT Publication Date:
20/03/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
22/01/2020
EP B1 Publication Date:
22/01/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
17/09/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
15/01/2020
 
 

Name:
Galectin Therapeutics Inc.
Address:
4960 Peachtree Industrial Blvd. Suite 240, Norcross, GA 30071, United States (US)

Name:
Providence Health & Services Oregon d/b/a Earle A. Chiles Research Institute of the Robert W. Franz Cancer Res. Cent. at Providence Port. Med. Cen.
Address:
4805 NE Gilsan Street, 2N35, Portland, OR 97213, United States (US)

Agent

Name:
Dennemeyer & Associates S.A.
From:
21/02/2020
Address:
55, rue des Bruyères, L-1274, HOWALD, Luxembourg (LU)
To:

Inventor

1

Name:
KLYOSOV, Anatole
Address:
United States (US)

2

Name:
TRABER, Peter, G.
Address:
United States (US)

3

Name:
ZOMER, Eliezer
Address:
United States (US)

4

Name:
LINCH, Stefanie, N.
Address:
United States (US)

5

Name:
REDMOND, William,L.
Address:
United States (US)

Priority

1

Priority Number:
201261701914 P
Priority Date:
17/09/2012
Priority Country:
United States (US)

2

Priority Number:
201361756818 P
Priority Date:
25/01/2013
Priority Country:
United States (US)

3

Priority Number:
201361759532 P
Priority Date:
01/02/2013
Priority Country:
United States (US)

Classification

IPC classification:
A01N 43/04; C07H 15/04;

Publication

European Patent Bulletin

Issue number:
202004
Publication date:
22/01/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
30/09/2025
Annual Fee Number:
13
Annual Fee Amount:
180 Euro
Expected Payer:
Last Annual Fee Payment Date:
13/09/2024
Last Annual Fee Paid Number:
12
Last Annual Fee Paid Amount:
165 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
21/02/2020 Power Of Attorney 3
21/02/2020 Power Of Attorney 3
21/02/2020 Outgoing Correspondence 1